Rgs14 is a protein that acts as a regulator of G-protein signaling pathways by accelerating the GTPase activity of G-protein alpha subunits and thereby converting them to their inactive GDP-bound form. The impact of Rgs14 expression on inflammatory bowel disease was investigated in a mouse model.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- What biomarkers reveal about "biological youth" - and what not (yet)
Epigenetic ageing
- Amyotrophic lateral sclerosis and nutrition
Calorie optimization in ALS through digital intervention
- "Forgotten axis" between plant substances, gut and systemic health
Microbiome and phytotherapy
- HIV: updated EACS guideline
Individualized approach to sustainable prevention and care
- Evidence-based diagnostics and treatment in the medical setting
Anxiety and depression disorders in adolescence
- Neuroenhancement
Can you swallow intelligence? Relevant substance classes times for healthy people
- Microbiome, inflammaging and affective/cognitive health
Gut-brain axis in old age
- Vitiligo - the level of suffering should not be underestimated